Skip to content

RLYB

Rallybio Corporation

NASDAQ · Healthcare · Biotechnology · US

$16.93
+0.30%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+6.0%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jul 10, 2026Boudreau Helen M · directorM-Exempt3,562$2.38
May 20, 2026ADAR1 Capital Management, LLC · 10 percent ownerPurchase200$14
May 20, 2026ADAR1 Capital Management, LLC · 10 percent ownerPurchase6,009$14
May 20, 2026ADAR1 Capital Management, LLC · 10 percent ownerPurchase10,000$14
May 15, 2026ADAR1 Capital Management, LLC · 10 percent ownerPurchase200$14
May 15, 2026ADAR1 Capital Management, LLC · 10 percent ownerPurchase4,081$14
May 15, 2026ADAR1 Capital Management, LLC · 10 percent ownerPurchase75,178$14
May 15, 2026ADAR1 Capital Management, LLC · 10 percent ownerPurchase100$14
May 13, 2026ADAR1 Capital Management, LLC · 10 percent ownerPurchase19,900$14
May 13, 2026ADAR1 Capital Management, LLC · 10 percent ownerPurchase5,100$14
May 13, 2026ADAR1 Capital Management, LLC · 10 percent ownerPurchase25,000$14
May 13, 2026ADAR1 Capital Management, LLC · 10 percent ownerPurchase800$14
May 6, 2026ADAR1 Capital Management, LLC · 10 percent ownerPurchase3,900$14
May 6, 2026ADAR1 Capital Management, LLC · 10 percent ownerPurchase35,101$14
May 6, 2026ADAR1 Capital Management, LLC · 10 percent ownerPurchase116,904$14
Feb 23, 2026Lieber Jonathan I · officer: Chief Financial OfficerA-Award2,500$0.00
Feb 23, 2026Lieber Jonathan I · officer: Chief Financial OfficerSale789$5.06
Feb 20, 2026HUNT RONALD · directorA-Award14,305$4.45
Feb 20, 2026MACKAY MARTIN · directorA-Award18,055$4.45
May 15, 2025Soteropoulos Paula · directorA-Award28,500$0.30
May 15, 2025Hopfner Robert Lorne · directorA-Award28,500$0.30
May 15, 2025Nash Christine A · directorA-Award28,500$0.30
May 15, 2025HUNT RONALD · directorA-Award28,500$0.30
May 15, 2025Boudreau Helen M · directorA-Award28,500$0.30
May 15, 2025MACKAY MARTIN · directorA-Award28,500$0.30
May 15, 2025Liu Hui · directorA-Award28,500$0.30
May 15, 2025Chung Wendy · directorA-Award28,500$0.30
Feb 19, 2025Ryder Steven · officer: Chief Medical OfficerA-Award180,000$0.76
Feb 19, 2025Lieber Jonathan I · officer: Chief Financial OfficerA-Award180,000$0.76
Feb 19, 2025Uden Stephen · director, officer: Chief Executive OfficerA-Award453,700$0.76
Institutional positioning

13F filings over the trailing two quarters

New 13Increased 3Reduced 23Sold out 38
FilerActionSharesFiled
JOHNSON & JOHNSONUnchanged3,636,363Mar 18, 2026
FMR LLCReduced793,451May 15, 2026
VIKING GLOBAL INVESTORS LPReduced524,347May 15, 2026
CORMORANT ASSET MANAGEMENT, LPNew Position400,000May 15, 2026
TPG GP A, LLCReduced378,551May 15, 2026
BALYASNY ASSET MANAGEMENT L.P.New Position376,573May 15, 2026
LAURION CAPITAL MANAGEMENT LPNew Position302,756May 14, 2026
NANTAHALA CAPITAL MANAGEMENT, LLCNew Position300,635May 15, 2026
PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLCReduced300,579May 14, 2026
5AM VENTURE MANAGEMENT, LLCReduced291,788May 15, 2026
ALMITAS CAPITAL LLCReduced191,206May 15, 2026
RENAISSANCE TECHNOLOGIES LLCReduced156,527May 14, 2026
JOHNSON & JOHNSONReduced152,901May 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position112,040May 15, 2026
AJU IB INVESTMENT CO., LTD.Reduced94,334May 8, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 10, 2026